Repigmentation of hair associated with melanoma in situ of scalp  by Tiger, Jeffrey B. et al.
Fig 1. Repigmented hair overlying melanoma in situ of
scalp. Slowly darkening patch of previously white hair on
superior scalp.
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Repigmentation of hair associated with
melanoma in situ of scalp
To the Editor: An 88-year-old woman presented
with a slowly darkening patch of previously white
hair on her superior scalp (Fig 1). On physical
examination, she had an underlying 6.5- 3 3-cm
scaly, irregularly pigmented plaque on her superior
scalp.
A shave biopsy of the plaque showed actinic
keratosis as well as melanoma in situ, lentigomaligna
type, extending along the dermoepidermal junction
and down the hair follicle. Further scouting punch
biopsies were performed to identify the extent of
disease, including peripheral areas that contained
pigmented hair shafts despite clinically normal-
appearing epidermis. Histopathology of these repeat
biopsies showed multiple foci of actinic keratosis
and a few areas with atypical melanocytes suspicious
for, but not diagnostic of, melanoma in situ.
Interestingly, there were 2 areas that showed
pigmented hair shafts and hair bulbs with
histopathologically normal dendritic melanocytesOpen access under CC BY-NC-ND license.and no evidence of overlying melanoma in situ or
actinic keratosis.
Normal hair follicle pigmentation and physiologic
graying are under complex genetic, metabolic,
enzymatic, and signaling control.1,2 The mechanism
responsible for our patient’s follicular repigmenta-
tion is unclear, although we believe it is most
likely due to her overlying melanoma in situ or
chronic sun damage. It is unlikely due to
medication use because the patient was not taking
any medications previously associated with hair
repigmentation.
Because the dendritic melanocytes in our
patient’s hair bulb appeared normal on histologic
examination, the follicular melanocytes were more
likely stimulated to produce melanin by external
signals rather than by a direct effect of melanoma
cells repopulating the hair bulb. These signals
could be from the lentigo maligna cells themselves
or by changes in the microenvironment. To our
knowledge, there is 1 previously reported case
of hair repigmentation associated with lentigo
maligna, which also showed no invasion of the
hair follicles by the melanoma cells.3 In that case,
the patient’s hair grew back gray after the
melanoma was treated by radiotherapy, suggesting
that normal hair physiology was restored once
the malignant cells were removed. If these
signals arise from the lentigo maligna, it would
be interesting to clarify how the neoplastic
cells could upregulate melanogenesis in nearby
normal follicular melanocytes, and which of the
numerous cytokines, enzymes, and metabolites
required for normal pigmentation were involved
in the process.
The repigmentationcouldalsobe related to chronic
sun exposure and actinic damage, as evidenced by the
presence of actinic keratoses. In particular, chronic
sun exposure causes upregulation of manymolecules
associated with melanogenesis, including stem cell
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receptor, and tyrosinase.1,4
Whereas graying is considered part of the
normal aging process, hair repigmentation is rare
and may even indicate an underlying pathology
such as melanoma in situ, as in this case. Now
that there have been at least 2 reported cases
of hair repigmentation associated with lentigo
maligna, this clinical sign should alert the
physician to a potential underlying cutaneous
malignancy.
More research is warranted to further investigate
the mechanisms of repigmentation. It would be of
great clinical significance if these pathways could be
understood and used to treat the underlying
malignancy or even to safely repigment white and
graying hair for cosmetic purposes.
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case and review of literature identifying chest
wall predominance and no recurrence
following skin grafts
To the Editor: Acute postoperative pyoderma
gangrenosum (PPG) is a rare ulcerative cutaneous
disease often misdiagnosed as a postoperative
wound infection. The etiology of PG is unknown,
although abnormal neutrophil chemotaxis has
been implicated.1 Most recently, a novel mutation
in PSTPIP1, which encodes a cytoskeletal adaptor
protein that inhibits macrophage function, was
identified in a patient with aggressive PG. The
mutated protein induced filopodia formation in
macrophages and led to increased matrix degrada-
tion.2 We present a patient seen at our institution and
key findings from analysis of 90 episodes of PPG in
87 patients from the literature.
A 30-year-old woman with a history of hypogam-
maglobulinemia presented with bilateral breast
wound breakdown 6 days after breast reduction
surgery. Shewas febrile with awhite blood cell count
of 18.8 (103/L). Cultures from the right breast
wounds were positive for Pseudomonas aeruginosa.
She was treated with multiple antibiotics and
repeated surgical debridement without improve-
ment. On examination, there was necrotic eschar
overlying bilateral breast ulcers with surrounding
superficial bullae and intense erythema. A perile-
sional biopsy demonstrated a dense neutrophilic
dermal infiltrate without evidence of vasculitis or
infection; special stains for bacteria were negative.
PPG was diagnosed and the patient was started on
methylprednisolone 60 mg 4 times daily and cyclo-
sporine 300 mg daily with improvement noted
within 48 hours. The patient was discharged on a
prednisone taper and cyclosporine 300 mg daily.
Complete healing occurred in 3 months.
The patient elected to undergo bilateral transverse
rectus abdominis myocutaneous flap breast recon-
struction surgery 6 months after her initial surgery.
Preoperatively, she continued cyclosporine 300 mg
daily. Again, diffuse wound breakdown occurred 5
days postoperatively. Cyclosporine was continued
and the patient was started on methylprednisolone
30 mg every 6 hours with rapid improvement and
healing 4 months later.
In review of 76 published articles, 106 PPG cases
were identified. Of these, 87 patients undergoing 90
procedures met criteria for developing wound break-
down within 21 days following surgery, consistent
with acute PPG (Table I), and were included in the
analysis. PPG was reported following surgery
involving the chest wall in 42 cases (47%) (Fig 1).
